Talks about TORCs, recent advances in target of rapamycin signalling

Target of rapamycin (TOR) is a eukaryotic protein kinase that forms TOR complexes 1 and 2, (m)TORC1/2, which contain distinct components and phosphorylate different substrates. This conference will cover the regulation of the TOR complexes, the many roles that these complexes play in cellular regulation, and their involvement in human diseases such as cancers.


mTOR signalling networks
Growth regulation
Nutrient sensing
Regulation of autophagy
Crosstalk with signalling pathways
Drugging the mTOR pathway
TOR in lower eukaryotes
mTOR in animal physiology
mTOR in human disease

+ show speakers and program

Sir Philip Randle Lecture
Gerald Shulman (Yale University, U.S.A.)
Brendan Manning (Harvard School of Public Health, U.S.A.)
David Sabatini (Massachusetts Institute of Technology, U.S.A.)
Doreen Cantrell (University of Dundee, United Kingdom)
Estela Jacinto (UMDNJ-Robert Wood Johnson Medical School, U.S.A.)
Linda Partridge (University College London, United Kingdom)
Mario Pende (Inserm U845, Université Paris Descartes, France)
Michael Hall (University of Basel, Switzerland)
Robbie Loewith (University of Geneva, Switzerland)

14 Mar - 15 Mar 2013
United Kingdom
meeting website